Published in Hepatitis Weekly, September 24th, 2007
"The subjects were categorized into four groups. Group A (n=45) healthy subjects (control); group B (n=49) chronic hepatitis B patients; group C (n=54) chronic hepatitis C patients; group D (n=98) liver cirrhosis patients....
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.